Acer Therapeutics Inc. (ACER)
Company Info
| ISIN | US00444P1084 |
|---|---|
| CUSIP | 00444P108 |
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | $16.15M |
|---|---|
| EPS | -$1.93 |
| Revenue (TTM) | $360.00K |
| Gross Profit (TTM) | $1.26M |
| EBITDA (TTM) | -$19.73M |
| Year Range | $0.55 - $4.56 |
| Target Price | $1.50 |
| Short % | 2.61% |
| Short Ratio | 2.87 |
Share Price Chart
Loading data...
Performance
The chart shows the growth of an initial investment of $10,000 in Acer Therapeutics Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Compare to other instruments
Return
Acer Therapeutics Inc. had a return of -73.70% year-to-date (YTD) and -44.61% in the last 12 months. Over the past 10 years, Acer Therapeutics Inc. had an annualized return of -42.72%, while the S&P 500 had an annualized return of 9.71%, indicating that Acer Therapeutics Inc. did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -73.70% | 18.52% |
| 1 month | -21.88% | 10.52% |
| 6 months | -27.14% | 8.20% |
| 1 year | -44.61% | 13.02% |
| 5 years (annualized) | -51.33% | 10.68% |
| 10 years (annualized) | -42.72% | 9.71% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 15.70% | 1.41% | 3.75% | -5.78% | 47.13% | -36.33% | 3.09% |
Risk-Adjusted Performance
This table presents a comparison of risk-adjusted performance metrics for Acer Therapeutics Inc. (ACER) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
|---|---|---|---|---|---|
ACER Acer Therapeutics Inc. | -0.26 | ||||
^GSPC S&P 500 | 0.91 |
Dividend History
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Acer Therapeutics Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Acer Therapeutics Inc. was 100.00%, occurring on Aug 25, 2023. The portfolio has not yet recovered.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -100% | Aug 16, 2000 | 4695 | Aug 25, 2023 | — | — | — |
| -66.67% | Apr 25, 2000 | 4 | May 8, 2000 | 28 | Aug 11, 2000 | 32 |
| -25% | Mar 23, 2000 | 1 | Mar 23, 2000 | 2 | Apr 4, 2000 | 3 |
Volatility Chart
The current Acer Therapeutics Inc. volatility is 25.64%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.